Search Results - "Atorrasagasti, Catalina"
-
1
The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease
Published in Journal of physiology and biochemistry (01-11-2023)“…Secreted protein acidic and rich in cysteine (SPARC) is an extracellular matrix glycoprotein with pleiotropic functions, which is expressed in adipose,…”
Get full text
Journal Article -
2
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
Published in Journal of hepatology (01-07-2019)“…[Display omitted] •Mutations and expression alterations of epigenetic modifiers are frequent in HCC.•Jumonji lysine demethylase inhibitors normalize aggressive…”
Get full text
Journal Article -
3
4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
Published in Scientific reports (18-03-2021)“…Hepatocellular carcinoma (HCC) arises in the setting of advanced liver fibrosis, a dynamic and complex inflammatory disease. The tumor microenvironment (TME)…”
Get full text
Journal Article -
4
Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice
Published in Gene therapy (01-02-2020)“…Extracellular vesicles (EVs) can mediate mesenchymal stromal cells (MSCs) paracrine effects. We aimed to evaluate the therapeutic potential of human umbilical…”
Get full text
Journal Article -
5
Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
Published in Cells (Basel, Switzerland) (11-11-2020)“…Non-alcoholic fatty liver disease (NAFLD) is defined clinicopathologically by the accumulation of lipids in >5% of hepatocytes and the exclusion of secondary…”
Get full text
Journal Article -
6
SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
Published in Scientific reports (15-01-2018)“…Mechanisms that control progression from simple steatosis to steato-hepatitis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) are…”
Get full text
Journal Article -
7
Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling
Published in Stem cell research (01-09-2023)“…The arrhythmogenic cardiomyopathy (ACM) is an inherited heart muscle disease characterized by the progressive replacement of contractile myocardium by…”
Get full text
Journal Article -
8
Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice
Published in International journal of molecular sciences (31-05-2023)“…New therapeutic options for liver cirrhosis are needed. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) have emerged as a promising tool for…”
Get full text
Journal Article -
9
Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma
Published in Stem cell research & therapy (11-07-2024)“…Mesenchymal stromal cells (MSCs) tropism for tumours allows their use as carriers of antitumoural factors and in vitro transcribed mRNA (IVT mRNA) is a…”
Get full text
Journal Article -
10
4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis
Published in Glycobiology (Oxford) (01-08-2015)“…Cirrhosis is characterized by an excessive accumulation of extracellular matrix components including hyaluronic acid (HA) and is widely considered a…”
Get full text
Journal Article -
11
Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
Published in International journal of molecular sciences (01-10-2023)“…The severity of non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to steatohepatitis, and it is not yet clearly understood which patients…”
Get full text
Journal Article -
12
Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice
Published in Stem cells and development (15-03-2015)“…Liver cirrhosis involves chronic wound healing and fibrotic processes. Mesenchymal stromal cells (MSCs) are multipotent adult progenitor cells that are used as…”
Get more information
Journal Article -
13
Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
Published in International journal of molecular sciences (11-05-2021)“…Liver fibrosis results from many chronic injuries and may often progress to cirrhosis and hepatocellular carcinoma (HCC). In fact, up to 90% of HCC arise in a…”
Get full text
Journal Article -
14
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice
Published in PloS one (11-02-2013)“…Secreted Protein, Acidic and Rich in Cysteine (SPARC) is a matricellular protein involved in many biological processes and found over-expressed in cirrhotic…”
Get full text
Journal Article -
15
Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
Published in Stem cell research & therapy (22-11-2016)“…Cirrhosis is a major health problem worldwide and new therapies are needed. Hepatic macrophages (hMø) have a pivotal role in liver fibrosis, being able to act…”
Get full text
Journal Article -
16
Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells
Published in International journal of cancer (01-06-2010)“…Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer‐related death worldwide. Current treatments are extremely…”
Get full text
Journal Article -
17
A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
Published in Clinical cancer research (01-12-2009)“…Purpose: Interleukin-12 (IL-12) is an immunostimulatory cytokine with potent antitumor effects in several animal models. However, serious toxicity has been…”
Get full text
Journal Article -
18
Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats
Published in The journal of gene medicine (01-09-2008)“…Background The interaction between fibrogenic cells and extracellular matrix plays a role in liver fibrosis, yet the mechanisms are largely unknown. Secreted…”
Get full text
Journal Article -
19
Immunotherapy and immunoescape in colorectal cancer
Published in World journal of gastroenterology : WJG (28-11-2007)“…Immunotherapy encompasses a variety of interventions and techniques with the common goal of eliciting tumor cell destructive immune responses. Colorectal…”
Get full text
Journal Article -
20
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
Published in Oncoimmunology (01-10-2012)“…The use of conventional cytotoxic agents at metronomic schedules, alone or in combination with targeted agents or immunotherapy, is being explored as a…”
Get full text
Journal Article